Literature DB >> 31784974

Development of isoporous microslit silicon nitride membranes for sterile filtration applications.

Evan Wright1, Joshua J Miller2, Matthew Csordas1, Andrew R Gosselin2, Jared A Carter2, James L McGrath3, David R Latulippe1, James A Roussie2.   

Abstract

The widely used 0.2/0.22 µm polymer sterile filters were developed for small molecule and protein sterile filtration but are not well-suited for the production of large nonprotein biological therapeutics, resulting in significant yield loss and production cost increases. Here, we report on the development of membranes with isoporous sub-0.2 μm rectangular prism pores using silicon micromachining to produce microslit silicon nitride (MSN) membranes. The very high porosity (~33%) and ultrathin (200 nm) nature of the 0.2 µm MSN membranes results in a dramatically different structure than the traditional 0.2/0.22 µm polymer sterile filter, which yielded comparable performance properties (including gas and hydraulic permeance, maximum differential pressure tolerance, nanoparticle sieving/fouling behavior). The results from bacteria retention tests, conducted according to the guidance of regulatory agencies, demonstrated that the 0.2 µm MSN membranes can be effectively used as sterile filters. It is anticipated that the results and technologies presented in this study will find future utility in the production of non-protein biological therapeutics and in other biological and biomedical applications.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  biological therapeutics; silicon nanomembranes; sterile filtration

Year:  2019        PMID: 31784974      PMCID: PMC7015775          DOI: 10.1002/bit.27240

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  10 in total

1.  Influence of size, shape, and flexibility on bacterial passage through micropore membrane filters.

Authors:  Yingying Wang; Frederik Hammes; Marcel Düggelin; Thomas Egli
Journal:  Environ Sci Technol       Date:  2008-09-01       Impact factor: 9.028

2.  Microscopic Characterization of Brevundimonas diminuta in the Hydrated State.

Authors:  Gary Harp; Seok-Jun Cho; Elisabeth Lester; David Rose; Chandran Sabanyagam; Scott F Ross
Journal:  PDA J Pharm Sci Technol       Date:  2015 May-Jun

Review 3.  Bacterial cell size and surface charge characteristics relevant to filter validation studies.

Authors:  M W Mittelman; M W Jornitz; T H Meltzer
Journal:  PDA J Pharm Sci Technol       Date:  1998 Jan-Feb

4.  Production of CGMP-Grade Lentiviral Vectors.

Authors:  Lara J Ausubel; Christine Hall; Anupriya Sharma; Rebecca Shakeley; Patricia Lopez; Valerie Quezada; Sylvana Couture; Kenneth Laderman; Ross McMahon; Patricia Huang; David Hsu; Larry Couture
Journal:  Bioprocess Int       Date:  2012-02

5.  Downstream processing of lentiviral vectors: releasing bottlenecks.

Authors:  Vanessa Bandeira; Cristina Peixoto; Ana F Rodrigues; Pedro E Cruz; Paula M Alves; Ana S Coroadinha; Manuel J T Carrondo
Journal:  Hum Gene Ther Methods       Date:  2012-08-30       Impact factor: 2.396

6.  Production and characterization of clinical grade exosomes derived from dendritic cells.

Authors:  Henry G Lamparski; Anita Metha-Damani; Jenq-Yuan Yao; Sanjay Patel; Di-Hwei Hsu; Curtis Ruegg; Jean-Bernard Le Pecq
Journal:  J Immunol Methods       Date:  2002-12-15       Impact factor: 2.303

7.  High-Performance Silicon Nanopore Hemofiltration Membranes.

Authors:  William H Fissell; Anna Dubnisheva; Abigail N Eldridge; Aaron J Fleischman; Andrew L Zydney; Shuvo Roy
Journal:  J Memb Sci       Date:  2009-01-05       Impact factor: 8.742

8.  Nanoporous silicon nitride membranes fabricated from porous nanocrystalline silicon templates.

Authors:  J P S DesOrmeaux; J D Winans; S E Wayson; T R Gaborski; T S Khire; C C Striemer; J L McGrath
Journal:  Nanoscale       Date:  2014-08-08       Impact factor: 7.790

9.  Permeability - Selectivity Analysis for Ultrafiltration: Effect of Pore Geometry.

Authors:  Dharmesh M Kanani; William H Fissell; Shuvo Roy; Anna Dubnisheva; Aaron Fleischman; Andrew L Zydney
Journal:  J Memb Sci       Date:  2010-03-01       Impact factor: 8.742

10.  Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes.

Authors:  Theone C Kon; Adrian Onu; Laurentiu Berbecila; Emilia Lupulescu; Alina Ghiorgisor; Gideon F Kersten; Yi-Qing Cui; Jean-Pierre Amorij; Leo Van der Pol
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.